Randomized, controlled, multisite, subject- and observer-masked, contralateral clinical trial of 6-month duration to compare two SightGlass Vision Diffusion Optics Technology (DOT) spectacle lens manufacturing processes in reducing the progression of juvenile myopia.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
50
Subjects randomized to test vs control, left eyes and right eyes
Sabal Eye Care
Longwood, Florida, United States
Kannarr Eye Care
Pittsburg, Kansas, United States
Advanced Eyecare PC
Raytown, Missouri, United States
SUNY School of Optometry
New York, New York, United States
Change in Axial Length Progression From Baseline
Change in axial length progression over time between DOT spectacle lenses manufactured by method A versus method B Axial length progression is defined as an axial length elongation that is attributable to myopia.
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
William J Bogus, OD, FAAO
Salt Lake City, Utah, United States